Every day, the sun rises on Wall Street, and a plethora of professional analysts wake to issue new opinions on stocks. Here at the Fool, we use our "This Just In" column to examine some of these picks-- and the track record of the firms behind them -- so individuals can make better investing decisions.
In addition to following these professional banks, anyone can use Motley Fool CAPS to monitor the collective opinions of more than 120,000 members, many of whom demonstrate better investing insight than published analysts do.
Like other large, diversified consumer companies such as Procter & Gamble
What's behind that consistent cash flow is one of the world's most-recognized brands -- one that is embedded in even remote regions and cultures. Like Pfizer
At this point, Coca-Cola is still expanding at a solid clip. In the most recent quarter, earnings per share grew by 14% and revenues grew 9%. Its Coke Zero brand grew unit case volume by 30% in the U.S. and is now sold in more than two dozen countries. The company sees emerging markets as key to growth, and although PepsiCo
The Motley Fool Inside Value service looks for value in shares of strong companies trading at cheap prices. To see what companies the analyst team believes are priced far below intrinsic value today, take a free 30-day trial. There's no obligation to subscribe.
Fool contributor Dave Mock drank two Cokes with his turkey to help offset the L-tryptophan, but it didn't work. Dave owns shares of Pfizer, Coca-Cola, and Intel. Pfizer is an Income Investor selection. Pfizer, Coca-Cola, and Intel are Inside Value selections. The Fool owns shares of Pfizer and Intel, as well as covered call options on Intel. The Fool has a disclosure policy.